<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>Subtitle 50 TISSUE BANKS | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/10.50/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/10.50/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|10|50|"/>
    <meta itemprop="doc-type" content="container" data-document=""/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="10|50" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="http://regs.maryland.gov//us/md/exec/comar/10.50"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content="Subtitle 50 TISSUE BANKS | Library of Maryland Regulations"/>
    <meta property="og:image" content="http://regs.maryland.gov//us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/10.50/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/10.50/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10" data-search-heading="">
                  <a href="/us/md/exec/comar/10" title="Title 10 MARYLAND DEPARTMENT OF HEALTH">Title 10 MARYLAND DEPARTMENT OF HEALTH</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|50" data-search-heading="">
                  <span title="Subtitle 50 TISSUE BANKS">Subtitle 50 TISSUE BANKS</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="10|50">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/md/exec/comar/10.50">Subtitle 50 TISSUE BANKS</h1>
                <h2 id="/us/md/exec/comar/10.50.01" data-order="|10|50|01|" data-ref-path="10|50|01" class="h__chapter">Chapter 01 Tissue Banks</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: July 1, 1970</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.01" title=".01 Purpose.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.12" title=".12 Tissue Bank Standards — Technical.">.12</a> repealed and new Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.01" title=".01 Purpose.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.06" title=".06 Permitting Procedure.">.06</a> adopted effective May 5, 1986 (13:9 Md. R. 1030)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.03" title=".03 Definitions.">Regulation .03</a> amended effective March 20, 1989 (16:5 Md. R. 629)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.06#B" title="">Regulation .06B</a> amended effective June 11, 1990 (17:11 Md. R. 1343)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.06#D" title="">Regulation .06D</a> amended effective March 20, 1989 (16:5 Md. R. 629); amended and recodified to Regulation .07 effective June 11, 1990 (17:11 Md. R. 1343)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.06#E" title="">Regulation .06E</a> adopted effective March 20, 1989 (16:5 Md. R. 629); recodified to Regulation .06D effective June 11, 1990 (17:11 Md. R. 1343)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.08" title=".08 Inspection by OHCQ.">Regulation .08</a> adopted effective June 11, 1990 (17:11 Md. R. 1343)</p>
                  <p>——————</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.02" title="Chapter 02 Medical Laboratories — General">COMAR 10.10.02</a> recodified to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01" title="Chapter 01 Tissue Banks">COMAR 10.50.01</a> effective December 13, 1999 (26:25 Md. R. 1897)</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.01" title=".01 Purpose.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.08" title=".08 Inspection by OHCQ.">.08</a> repealed and new Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.01" title=".01 Purpose.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.12" title=".12 Tissue Bank Standards — Technical.">.12</a> adopted effective March 15, 2004 (31:5 Md. R. 449)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.03#B" title="">Regulation .03B</a> amended effective April 4, 2011 (38:7 Md. R. 432); September 15, 2025 (52:18 Md. R. 923)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.04#B" title="">Regulation .04B</a> amended effective April 4, 2011 (38:7 Md. R. 432); August 15, 2016 (43:16 Md. R. 901); September 15, 2025 (52:18 Md. R. 923)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.05" title=".05 Responsibilities of the OHCQ. — Repealed.">Regulation .05</a> repealed effective September 15, 2025 (52:18 Md. R. 923)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.06" title=".06 Permitting Procedure.">Regulation .06</a> amended effective November 25, 2013 (40:23 Md. R. 1934)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.06" title=".06 Permitting Procedure.">Regulation .06</a> repealed and new Regulation .06 adopted effective September 15, 2025 (52:18 Md. R. 923)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.07#B" title="">Regulation .07B</a> amended effective September 15, 2025 (52:18 Md. R. 923)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.07#D" title="">Regulation .07D</a> adopted effective September 15, 2025 (52:18 Md. R. 923)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.08" title=".08 Inspection by OHCQ.">Regulation .08</a> recodified to be Regulation .09 effective September 15, 2025 (52:18 Md. R. 923)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.08" title=".08 Inspection by OHCQ.">Regulation .08</a> adopted effective September 15, 2025 (52:18 Md. R. 923)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.09" title=".09 Tissue Bank Standards — General.">Regulation .09</a> repealed effective September 15, 2025 (52:18 Md. R. 923)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.09" title=".09 Tissue Bank Standards — General.">Regulation .09</a> recodified from Regulation .08 effective September 15, 2025 (52:18 Md. R. 923)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.10" title=".10 Tissue Bank Standards — Personnel.">Regulation .10</a> amended effective September 15, 2025 (52:18 Md. R. 923)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.10#C" title="">Regulation .10C</a> amended effective January 9, 2012 (38:27 Md. R. 1764)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.11#A" title="">Regulation .11A</a> amended effective September 15, 2025 (52:18 Md. R. 923)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.50.01.11#A" title="">Regulation .11A</a>, C amended effective April 4, 2011 (38:7 Md. R. 432)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, Annotated Code of Maryland</p>
                </section>
                <div class="table_wrap">
                  <table class="layout-table">
                    <tbody>
                      <tr>
                        <td data-vertical-align="middle">Regulations</td>
                        <td data-vertical-align="middle">Sections</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">.01</td>
                        <td data-vertical-align="middle">17-302</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">.02</td>
                        <td data-vertical-align="middle">17-302</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">.03</td>
                        <td data-vertical-align="middle">17-301, 17-302</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">.04</td>
                        <td data-vertical-align="middle">17-302</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">.05</td>
                        <td data-vertical-align="middle">17-302, 17-307</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">.06</td>
                        <td data-vertical-align="middle">17-305, 17-313</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">.07</td>
                        <td data-vertical-align="middle">17-302</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">.08</td>
                        <td data-vertical-align="middle">17-302</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">.09</td>
                        <td data-vertical-align="middle">17-302</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">.10</td>
                        <td data-vertical-align="middle">17-302, 17-303</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">.11</td>
                        <td data-vertical-align="middle">17-302</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">.12</td>
                        <td data-vertical-align="middle">17-302</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <h3 id="/us/md/exec/comar/10.50.01.01" data-order="|10|50|01|.01|" data-ref-path="10|50|01|.01" class="h__section">.01 Purpose.</h3>
                <p>The intent of this chapter is to protect the public and individual health by requiring that all tissue banks operating or providing services in Maryland operate under qualified supervision, reliable procedures, and appropriate quality assurance.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.50.01.02" data-order="|10|50|01|.02|" data-ref-path="10|50|01|.02" class="h__section">.02 Scope.</h3>
                <p>This chapter does not apply to a tissue bank operated:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.02#A">A.</span> By the federal government; or</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.02#B">B.</span> Solely for research and teaching purposes, if human tissue and tissue products from the research or teaching are not transplanted, transfused, or used within or upon a human.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.50.01.03" data-order="|10|50|01|.03|" data-ref-path="10|50|01|.03" class="h__section">.03 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(1)">(1)</span> “Adverse outcome” means an undesirable effect or untoward complication in a recipient as a result of or reasonably related to a transfusion or transplantation of cells, tissue, or both.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(2)">(2)</span> “Allogeneic tissue” means tissue from a human donor intended for use within or upon the body of an individual other than the donor.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(3)">(3)</span> “Allograft” means cells, tissue, or both intended for transplantation into another individual of the same species.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(4)">(4)</span> “Approval of the removal plan” means that the OHCQ has determined that the tissue bank's removal plan, if implemented appropriately, will remove the likelihood that serious harm will occur, or recur.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(5)">(5)</span> “Autogeneic tissue” means tissue from a human donor intended for use within or upon the body of that same donor.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(6)">(6)</span> “Cardiovascular tissue” means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(6)(a)">(a)</span> Human heart valves;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(6)(b)">(b)</span> Aorta and great vessels;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(6)(c)">(c)</span> Pericardium;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(6)(d)">(d)</span> Saphenous vein;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(6)(e)">(e)</span> Umbilical vein; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(6)(f)">(f)</span> Other tissues of the cardiovascular system.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(7)">(7)</span> Collection.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(7)(a)">(a)</span> “Collection” means an activity involved in obtaining allogeneic or autogeneic tissue for the purpose of transplantation, transfusion, or transfer into or upon a human being.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(7)(b)">(b)</span> “Collection” includes the removal, acquisition, recovery, harvesting, or retrieval of donor tissue by any means, including:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(7)(b)(i)">(i)</span> Phlebotomy;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(7)(b)(ii)">(ii)</span> Hemapheresis;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(7)(b)(iii)">(iii)</span> Surgical excision; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(7)(b)(iv)">(iv)</span> Biopsy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(8)">(8)</span> “Designated qualified employee” means an employee who has been delegated one or more responsibilities by the technical director or medical director and who possesses the training and experience to perform the delegated responsibility.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(9)">(9)</span> “Department” means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(10)">(10)</span> “Distribution” means the removal of tissue or tissue products from the tissue bank originally collecting, storing, or processing the tissue for shipment to another person or facility for processing, storage, or a diagnostic, therapeutic, or prophylactic purpose.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(11)">(11)</span> “Donor” means a human being, living or dead, who is the source of tissue for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(11)(a)">(a)</span> Transplantation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(11)(b)">(b)</span> Transfer;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(11)(c)">(c)</span> Transfusion; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(11)(d)">(d)</span> Implantation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(12)">(12)</span> “Eye” means a human cornea or other ocular tissue.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(13)">(13)</span> “Hematopoietic progenitor cells” means human precursor stem or progenitor hematopoietic cells derived from bone marrow, peripheral blood, or other tissue sources.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(14)">(14)</span> “Immediate corrective action” means all actions the tissue bank has taken or will take to immediately address the noncompliance that resulted in or made serious harm or death likely.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(15)">(15)</span> “Immediate jeopardy” means a situation in which immediate corrective action is necessary because the tissue bank's noncompliance with one or more licensure requirements has already caused, is causing, or is likely to cause, at any time, serious harm or death, to individuals served by the tissue bank or to the health or safety of the general public.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(16)">(16)</span> “Informal dispute resolution (IDR)” means an informal process that provides a tissue bank the opportunity to dispute one or more deficiencies cited in a written statement of deficiencies issued by the Department or the Department’s designee related to a recent survey.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(17)">(17)</span> Leukocyte.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(17)(a)">(a)</span> “Leukocyte” means a nucleated white blood cell or a colorless blood corpuscle that:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(17)(a)(i)">(i)</span> Is found throughout the human body, including the blood, lymphatic system, and lymphoidal tissue;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(17)(a)(ii)">(ii)</span> Is produced and derived from hematopoietic progenitor cells in the bone marrow; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(17)(a)(iii)">(iii)</span> Functions to protect the body against infectious microorganisms that cause disease by phagocytosis of the microorganisms and by producing antibodies.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(17)(b)">(b)</span> “Leukocyte” includes any of the various white blood cells classified as a granulocyte or agranulocyte that collectively make up the human immune system, including:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(17)(b)(i)">(i)</span> Neutrophils, also known as polymorphonuclear leukocytes;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(17)(b)(ii)">(ii)</span> Eosinophils;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(17)(b)(iii)">(iii)</span> Basophils;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(17)(b)(iv)">(iv)</span> Monocytes;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(17)(b)(v)">(v)</span> Lymphocytes; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(17)(b)(vi)">(vi)</span> Thrombocytes, also known as platelets.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(18)">(18)</span> Leukocyte-Poor Tissue.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(18)(a)">(a)</span> “Leukocyte-Poor tissue” means tissue that does not contain a significant or substantial number of potentially viable leukocytes.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(18)(b)">(b)</span> “Leukocyte-Poor tissue” includes but is not limited to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(18)(b)(i)">(i)</span> Corneas;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(18)(b)(ii)">(ii)</span> Sclera;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(18)(b)(iii)">(iii)</span> Skin;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(18)(b)(iv)">(iv)</span> Heart valves;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(18)(b)(v)">(v)</span> Dura mater;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(18)(b)(vi)">(vi)</span> Oocytes; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(18)(b)(vii)">(vii)</span> Musculoskeletal tissue, including bone, tendons, ligaments, and cartilage oocytes, if cleansed, washed, and rendered leukocyte-reduced.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(19)">(19)</span> Leukocyte-Rich Tissue.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(19)(a)">(a)</span> “Leukocyte-Rich tissue” means tissue that may contain a significant or substantial number of potentially viable leukocytes.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(19)(b)">(b)</span> “Leukocyte-Rich tissue” includes but is not limited to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(19)(b)(i)">(i)</span> Blood, blood components, and products prepared after blood collection;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(19)(b)(ii)">(ii)</span> Hematopoietic progenitor cells, also known as stem cells;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(19)(b)(iii)">(iii)</span> Bone marrow;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(19)(b)(iv)">(iv)</span> Musculoskeletal tissue containing blood or marrow elements, including unprocessed, fresh or frozen, or whole or partial bone;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(19)(b)(v)">(v)</span> Musculoskeletal tissue allografts in which the bone end and subchondral bone element have not been cleansed, washed, and rendered leukocyte-reduced; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(19)(b)(vi)">(vi)</span> Semen.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(20)">(20)</span> “Medical director” means a physician who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(20)(a)">(a)</span> Meets the requirements set forth in <a class="internal-link " href="/us/md/exec/comar/10.50.01.10" title=".10 Tissue Bank Standards — Personnel.">Regulation .10 of this chapter</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(20)(b)">(b)</span> Is responsible for all medical aspects of the tissue bank's operations, unless the technical director meets the qualifications  stated in <a class="internal-link " href="/us/md/exec/comar/10.50.01.10#B" title="">Regulation .10B of this chapter</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(21)">(21)</span> “Milk” means human milk for ingestion by a child other than the milk donor's child.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(22)">(22)</span> “Musculoskeletal tissue” means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(22)(a)">(a)</span> Bone;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(22)(b)">(b)</span> Tendon;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(22)(c)">(c)</span> Ligament;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(22)(d)">(d)</span> Muscle;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(22)(e)">(e)</span> Fascia;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(22)(f)">(f)</span> Cartilage; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(22)(g)">(g)</span> Other tissue in the musculoskeletal system.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(23)">(23)</span> “Need for immediate corrective action” means immediate corrective action is necessary to remove the jeopardy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(24)">(24)</span> “Noncompliance” means the tissue bank is not compliant with one or more licensure requirements.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(25)">(25)</span> “OHCQ” means the Office of Health Care Quality in the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(26)">(26)</span> “Owner” means a person with an ownership interest in a tissue bank.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(27)">(27)</span> Permit.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(27)(a)">(a)</span> “Permit” means a license issued by the Secretary to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(27)(a)(i)">(i)</span> Operate a tissue bank in this State; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(27)(a)(ii)">(ii)</span> Represent or service in this State a tissue bank that is in this State or outside this State.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(27)(b)">(b)</span> “Permit” includes a provisional permit, except as otherwise indicated in <a class="internal-link " href="/us/md/exec/comar/10.50.01.06" title=".06 Permitting Procedure.">Regulation .06 of this chapter</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(28)">(28)</span> “Plan of correction” means a written plan submitted by the tissue bank to the OHCQ which documents steps the tissue bank will take to come into compliance with the licensure requirements.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(29)">(29)</span> “Processing” means an activity necessary to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(29)(a)">(a)</span> Prepare or preserve a tissue for storage;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(29)(b)">(b)</span> Remove a tissue from storage; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(29)(c)">(c)</span> Conduct testing to assure the potency, quality, or sterility of a tissue.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(30)">(30)</span> “Recipient” means an individual who receives a tissue through:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(30)(a)">(a)</span> Transplantation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(30)(b)">(b)</span> Transfusion;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(30)(c)">(c)</span> Transfer; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(30)(d)">(d)</span> Implementation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(31)">(31)</span> “Removal plan” means the tissue bank's written plan that documents:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(31)(a)">(a)</span> The immediate corrective action a tissue bank will take to prevent serious harm from occurring or recurring;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(31)(b)">(b)</span> All actions to remove past, present, and future jeopardy; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(31)(c)">(c)</span> The date by which the entity asserts the likelihood for serious harm to any recipient no longer exists.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(32)">(32)</span> “Represent or service” means a mechanism, system, method, or activity that provides or offers to provide a tissue bank service to a person in the State.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(33)">(33)</span> Reproductive Tissue.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(33)(a)">(a)</span> “Reproductive tissue” means tissue from the reproductive tract intended for use in artificial insemination or another assisted reproductive procedure.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(33)(b)">(b)</span> “Reproductive tissue” includes, but is not limited to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(33)(b)(i)">(i)</span> Semen;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(33)(b)(ii)">(ii)</span> Oocytes;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(33)(b)(iii)">(iii)</span> Embryos;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(33)(b)(iv)">(iv)</span> Spermatozoa;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(33)(b)(v)">(v)</span> Spermatids;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(33)(b)(vi)">(vi)</span> Ovarian tissue;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(33)(b)(vii)">(vii)</span> Testicular tissue;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(33)(b)(viii)">(viii)</span> Epididymal aspirates; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(33)(b)(ix)">(ix)</span> Other tissue in the reproductive system.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(34)">(34)</span> Quality Control.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(34)(a)">(a)</span> “Quality control” means the daily analysis of procedures and materials to assure sterility, accuracy, and reproducibility of tissue and tissue bank products.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(34)(b)">(b)</span> “Quality control” includes a documented system to assure that instruments, equipment, reagents, and supplies function properly.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(35)">(35)</span> “Secretary” means the Secretary of the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(36)">(36)</span> “Serious harm” means the situation has already caused, is causing, or is likely to cause, at any time, serious injury, serious impairment, or death, to individuals served by the tissue bank or to the health or safety of the general public.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(37)">(37)</span> “Storage” means holding tissue for subsequent:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(37)(a)">(a)</span> Transplantation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(37)(b)">(b)</span> Transfusion;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(37)(c)">(c)</span> Transfer; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(37)(d)">(d)</span> Implantation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(38)">(38)</span> “Statement of Deficiencies” means the written notification that the OHCQ issues to the provider that contains a listing of deficiencies cited that require correction.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(39)">(39)</span> “Technical director” means an individual who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(39)(a)">(a)</span> Meets the requirements set forth in <a class="internal-link " href="/us/md/exec/comar/10.50.01.10" title=".10 Tissue Bank Standards — Personnel.">Regulation .10 of this chapter</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(39)(b)">(b)</span> Will oversee and be responsible for all technical aspects of the tissue bank's operations..</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(40)">(40)</span> Tissue.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(40)(a)">(a)</span> “Tissue” means a visceral or nonvisceral collection of human cells and their associated intracellular substances.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(40)(b)">(b)</span> “Tissue” includes, but is not limited to, human:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(40)(b)(i)">(i)</span> Blood, blood components, and products prepared after collection;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(40)(b)(ii)">(ii)</span> Cardiovascular tissue;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(40)(b)(iii)">(iii)</span> Cornea and other ocular tissue;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(40)(b)(iv)">(iv)</span> Hematopoietic progenitor cells;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(40)(b)(v)">(v)</span> Milk;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(40)(b)(vi)">(vi)</span> Musculoskeletal tissue;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(40)(b)(vii)">(vii)</span> Reproductive cells and tissue; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(40)(b)(viii)">(viii)</span> Skin.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(41)">(41)</span> Tissue Bank.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(41)(a)">(a)</span> “Tissue bank” means an establishment that obtains, stores, processes, distributes, or sells human blood or other human tissue for use in the human body.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(41)(b)">(b)</span> “Tissue bank” includes a person or facility that provides or engages in one or more services involving tissue from living or cadaveric donors for:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(41)(b)(i)">(i)</span> Transplantation;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(41)(b)(ii)">(ii)</span> Transfusion;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(41)(b)(iii)">(iii)</span> Transfer; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(41)(b)(iv)">(iv)</span> Implementation purposes.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(41)(c)">(c)</span> “Tissue bank” includes, but is not limited to, the following classes:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(41)(c)(i)">(i)</span> Blood bank;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(41)(c)(ii)">(ii)</span> Cardiovascular tissue bank;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(41)(c)(iii)">(iii)</span> Eye bank;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(41)(c)(iv)">(iv)</span> Hematopoietic progenitor cell bank;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(41)(c)(v)">(v)</span> Human milk bank;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(41)(c)(vi)">(vi)</span> Musculoskeletal tissue bank;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(41)(c)(vii)">(vii)</span> Reproductive tissue bank; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(41)(c)(viii)">(viii)</span> Skin bank.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(42)">(42)</span> Tissue Bank Service.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(42)(a)">(a)</span> “Tissue bank service” means an activity or pursuit that involves tissue intended for human:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(42)(a)(i)">(i)</span> Transplantation;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(42)(a)(ii)">(ii)</span> Transfusion;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(42)(a)(iii)">(iii)</span> Transfer; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(42)(a)(iv)">(iv)</span> Implementation.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(42)(b)">(b)</span> “Tissue bank service” includes, but is not limited to, an activity or means of donor selection or tissue:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(42)(b)(i)">(i)</span> Collection;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(42)(b)(ii)">(ii)</span> Preparation;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(42)(b)(iii)">(iii)</span> Preservation;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(42)(b)(iv)">(iv)</span> Storage;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(42)(b)(v)">(v)</span> Allocation;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(42)(b)(vi)">(vi)</span> Transportation; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.03#B(42)(b)(vii)">(vii)</span> Distribution.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.50.01.04" data-order="|10|50|01|.04|" data-ref-path="10|50|01|.04" class="h__section">.04 Incorporation by Reference.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.04#A">A.</span> In this chapter, the following documents are incorporated by reference.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.04#B">B.</span> Documents Incorporated.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.04#B(1)">(1)</span> Standards for Tissue Banking (American Association of Tissue Banks, 14th Edition), Sections C, D, E, F, G, H, J, K, L, and M1-8 only;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.04#B(2)">(2)</span> Standards for Blood Banks and Transfusion Services [(American Association of Blood Banks, 29th Edition);] (Association for the Advancement of Blood &amp; Biotherapies), 34th Edition;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.04#B(3)">(3)</span> International Quality Plasma Program (IQPP) (Plasma Protein Therapeutics Association):</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.04#B(3)(a)">(a)</span> Community-based Donor Standard V5 (2020);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.04#B(3)(b)">(b)</span> Cross Donation Management Standard V3 (2014);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.04#B(3)(c)">(c)</span> Recording Donor Adverse Events V2 (2018);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.04#B(3)(d)">(d)</span> Donor Education Standard V3 (2014);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.04#B(3)(e)">(e)</span> Donor Fluid Administration Standard V1 (2014);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.04#B(3)(f)">(f)</span> Use of National Donor Deferral Registry Standard V3 (2008);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.04#B(3)(g)">(g)</span> Qualified Donor Standard V5 (2020);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.04#B(3)(h)">(h)</span> Viral Marker Standard V5 (2022);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.04#B(3)(i)">(i)</span> Personnel Education and Training Standard V5 (2019);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.04#B(3)(j)">(j)</span> Plasma Collection Facility Standard V4 (2019);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.04#B(3)(k)">(k)</span> Quality Assurance Standard V5 (2020); and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.04#B(4)">(4)</span> 42 U.S.C. §§1320d et seq., as amended;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.04#B(5)">(5)</span> 42 U.S.C. §§17921 et seq., as amended; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.04#B(6)">(6)</span> 45 CFR Parts 160, 162, and 164, as amended.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.50.01.05" data-order="|10|50|01|.05|" data-ref-path="10|50|01|.05" class="h__section">.05 Responsibilities of the OHCQ. — Repealed.</h3>
                <h3 id="/us/md/exec/comar/10.50.01.06" data-order="|10|50|01|.06|" data-ref-path="10|50|01|.06" class="h__section">.06 Permitting Procedure.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#A">A.</span> Application. An application is not complete until the OHCQ has received the completed permit application and all required documents.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#B">B.</span> Initial Inspection. The OHCQ shall inspect or have an inspection conducted by an accreditation organization for each tissue bank when an initial Maryland permit to operate is sought.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#C">C.</span> Issuance of a Permit. The Secretary shall issue a permit to an applicant who meets the requirements of this chapter to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#C(1)">(1)</span> Operate a tissue bank in the State; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#C(2)">(2)</span> Represent for service in the State a tissue bank that is inside the State or outside the State.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#D">D.</span> Issuance of a Permit and Provisional Permit.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#D(1)">(1)</span> Permit and Provisional Permit Content. A permit and provisional permit shall state:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#D(1)(a)">(a)</span> The name of the tissue bank;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#D(1)(b)">(b)</span> The name of the tissue bank's medical director;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#D(1)(c)">(c)</span> The name of the tissue bank's owner or owners; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#D(1)(d)">(d)</span> The class or classes of the tissue bank.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#D(2)">(2)</span> Provisional Permit.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#D(2)(a)">(a)</span> The Secretary may issue a provisional permit before or after an initial inspection.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#D(2)(b)">(b)</span> A provisional permit:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#D(2)(b)(i)">(i)</span> Is valid for 180 calendar days or a lesser period as determined by the Secretary;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#D(2)(b)(ii)">(ii)</span> May not be renewed; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#D(2)(b)(iii)">(iii)</span> Shall automatically expire without notice upon the sooner of the date set for its expiration or upon issuance of a permit.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#E">E.</span> Permit Requirement. A person shall hold a permit issued by the Secretary before the person may:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#E(1)">(1)</span> Operate a tissue bank in this State; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#E(2)">(2)</span> Represent or service in this State a tissue bank that is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#E(2)(a)">(a)</span> In this State; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#E(2)(b)">(b)</span> Outside this State.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#F">F.</span> Operating Without a Permit.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#F(1)">(1)</span> Unless a person has a permit issued by the Secretary to operate, represent, or service a tissue bank in this State, a person may not:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#F(1)(a)">(a)</span> Operate a tissue bank in this State; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#F(1)(b)">(b)</span> Represent or service in this State a tissue bank that is in this State or outside this State.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#F(2)">(2)</span> A permit holder may not operate, represent, or service a tissue bank class other than that authorized in the permit.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#G">G.</span> Cessation of Operations.  If a tissue bank ceases operation for 180 calendar days, then:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#G(1)">(1)</span> The OHCQ will void the permit to operate a tissue bank in the State; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#G(2)">(2)</span> The tissue bank shall return the permit to the OHCQ.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#H">H.</span> Permit Application Administratively Closed.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#H(1)">(1)</span> After 180 calendar days from the date of initial receipt, the OHCQ may deem an incomplete permit application inactive and administratively close the application.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#H(2)">(2)</span> An applicant whose application is administratively closed may reapply for a permit by submitting a new application.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#I">I.</span> Change of Medical Director, Name, or Location of a Tissue Bank. A tissue bank undergoing a change in medical director, name, or location shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#I(1)">(1)</span> Notify the OHCQ 10 calendar days before a change occurs; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#I(2)">(2)</span> Apply to the OHCQ for an amended permit or provisional permit within 30 calendar days after a change takes place.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#J">J.</span> Nontransferability. A permit or provisional permit may not be transferred from one owner of a tissue bank to another.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#K">K.</span> Denial, Suspension, Revocation — Causes. The Secretary may deny, suspend, or revoke a permit or provisional permit if the tissue bank or the tissue bank's technical director, medical director, or both fail to meet requirements of this chapter, including, but not limited to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#K(1)">(1)</span> Failure within a specified time to correct a cited deficiency identified during an inspection;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#K(2)">(2)</span> Repetitive or consistent errors;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#K(3)">(3)</span> Deliberate falsehood; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#K(4)">(4)</span> Failure to apply for an amended permit or provisional permit within 30 calendar days after a tissue bank undergoes a change in tissue bank class, medical director, name, or location.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#L">L.</span> Denial, Suspension, and Revocation — Hearing Requirement.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#L(1)">(1)</span> When the Secretary denies an application for a permit, the Secretary shall inform the permit applicant in writing:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#L(1)(a)">(a)</span> Of the date the denial takes effect;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#L(1)(b)">(b)</span> Of the reason for the denial; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#L(1)(c)">(c)</span> That the permit applicant has an opportunity for a hearing on the matter in accordance with <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-226" title="">State Government Article, §10-226, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#L(2)">(2)</span> Unless the Secretary finds that a danger to public health, safety, or welfare summarily requires that emergency action be taken to correct a deficiency, the Secretary shall inform the permit holder or provisional permit holder, in writing:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#L(2)(a)">(a)</span> Of the date a suspension or revocation of the permit or provisional permit takes effect;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#L(2)(b)">(b)</span> Of the reason for the suspension or revocation; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#L(2)(c)">(c)</span> That the permit holder or provisional permit holder has an opportunity for a hearing on the matter before the suspension or revocation takes effect, in accordance with <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-226" title="">State Government Article, §10-226, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#L(3)">(3)</span> When a finding is made that the public health, safety, or welfare summarily requires that emergency or immediate corrective action be taken, the Secretary shall inform the permit holder or provisional permit holder in writing:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#L(3)(a)">(a)</span> Of the date a suspension or revocation of the permit or provisional permit takes effect;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#L(3)(b)">(b)</span> Of the reason for the suspension or revocation; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#L(3)(c)">(c)</span> That the permit holder or provisional permit holder has an opportunity for a hearing on the matter, after the suspension or revocation takes effect, in accordance with <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-226" title="">State Government Article, §10-226, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#L(4)">(4)</span> Reapplication After Revocation. A tissue bank that has had its permit or provisional permit revoked may apply for a new permit 30 calendar days after revocation and upon presentation to the Secretary of evidence of capability and intention to comply with the standards and requirements of this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.06#M">M.</span> Return of Permit. If a tissue bank's permit is amended, suspended, or revoked, the original permit is void and the tissue bank's technical director shall return the permit to the OHCQ.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.50.01.07" data-order="|10|50|01|.07|" data-ref-path="10|50|01|.07" class="h__section">.07 Accredited Tissue Bank and Accrediting Organization.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#A">A.</span> Accredited Tissue Bank — Determination. The Secretary may accept as compliance with the inspection requirements of this chapter a tissue bank accredited by an organization approved by the Secretary, as set forth in <a class="internal-link " href="/us/md/exec/comar/10.50.01.07#C" title="">§C of this regulation</a>, if the OHCQ determines that the standards of the tissue bank accrediting organization are equivalent to those under this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#B">B.</span> Accredited Tissue Bank — Requirements. In addition to meeting the requirements for accreditation, as set forth by a tissue bank's accrediting organization, an accredited tissue bank shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#B(1)">(1)</span> Obtain and maintain a valid permit issued by the Secretary; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#B(2)">(2)</span> Be subject to inspection by the OHCQ to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#B(2)(a)">(a)</span> Determine if the tissue bank is operating in a manner that does not constitute an imminent and serious risk to public health;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#B(2)(b)">(b)</span> Investigate complaints;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#B(2)(c)">(c)</span> Determine whether a permit holder is operating a tissue bank beyond the scope of the permit;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#B(2)(d)">(d)</span> Validate findings of a tissue bank's accrediting organization; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#B(2)(e)">(e)</span> Verify compliance with licensure requirements.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#C">C.</span> Accrediting Organization.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#C(1)">(1)</span> A private, nonprofit tissue-bank accrediting organization may inspect and accredit tissue banks in the State for the purpose of a State permit only after applying for and receiving approval of the OHCQ.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#C(2)">(2)</span> The OHCQ may approve a tissue bank accrediting organization based on a review of that organization, if the review includes (but need not be limited to) an evaluation of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#C(2)(a)">(a)</span> Accreditation policies and standards;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#C(2)(b)">(b)</span> Copies of inspection forms and guidelines;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#C(2)(c)">(c)</span> Inspection and deficiency writing policies;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#C(2)(d)">(d)</span> Inspector qualifications; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#C(2)(e)">(e)</span> Complaint investigation policies.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#C(3)">(3)</span> In addition to other requirements set forth in this chapter, an accrediting organization shall provide to the OHCQ:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#C(3)(a)">(a)</span> Annually, an updated list containing the names, addresses, and accreditation expiration dates of all tissue banks in the State accredited by the accrediting organization;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#C(3)(b)">(b)</span> Within 30 days after conducting an inspection, a certified written or electronic copy of each inspection report covering each tissue bank applying for or maintaining accreditation in the State;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#C(3)(c)">(c)</span> At least 30 days before the effective date of the change, written notice of any proposed change to requirements for tissue bank accreditation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#C(3)(d)">(d)</span> Within 30 days after a tissue bank's accreditation expires, written or electronic notice if the tissue bank does not renew its accreditation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#C(3)(e)">(e)</span> Documentation of a complaint and complaint investigation; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#C(3)(f)">(f)</span> On request, a copy of:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#C(3)(f)(i)">(i)</span> Inspector qualifications; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#C(3)(f)(ii)">(ii)</span> Other information the Secretary may require relating to the regulation of a tissue bank.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#C(4)">(4)</span> When the Secretary denies accreditation to a tissue-bank accrediting organization, the Secretary shall inform the accrediting agency in writing that it has an opportunity for a hearing under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-226" title="">State Government Article, §10-226, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.07#D">D.</span> Change in Accreditation Status. Tissue banks shall report all changes in accreditation status to the OHCQ within seven calendar days of becoming aware of the change.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.50.01.08" data-order="|10|50|01|.08|" data-ref-path="10|50|01|.08" class="h__section">.08 Inspection by OHCQ.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#A">A.</span> Open for Inspection.  A permit holder shall allow an on-site inspection by the OHCQ, or any designee by OHCQ, at any time during the tissue bank's regular hours of operation, to evaluate the tissue bank's compliance with the applicable requirements, conditions, and standards of this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#B">B.</span> Content of Inspection.  An inspection may include, but is not limited to, observation and examination of:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#B(1)">(1)</span> Tissue bank facilities and physical security;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#B(2)">(2)</span> Equipment;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#B(3)">(3)</span> Quality assurance and quality control policies and records;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#B(4)">(4)</span> Operating procedures, policies, and records;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#B(5)">(5)</span> Personnel and personnel records;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#B(6)">(6)</span> Donor documentation and records; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#B(7)">(7)</span> Other records and files pertinent to this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#C">C.</span> Access to Records. Tissue bank employees shall make data and records accessible within a reasonable time during an inspection by OHCQ or any designee by OHCQ.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#D">D.</span> Permitted Tissue Bank. A permit holder operating a tissue bank under a provisional permit or a permit shall be subject to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#D(1)">(1)</span> An initial inspection conducted by the OHCQ;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#D(2)">(2)</span> Periodic inspections by the OHCQ; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#D(3)">(3)</span> Other inspections by the OHCQ to determine if the tissue bank is in compliance with licensure requirements.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#E">E.</span> Accredited Tissue Bank. An accredited tissue bank is subject to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#E(1)">(1)</span> An initial inspection by an accreditation organization or the OHCQ;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#E(2)">(2)</span> Periodic inspections by an accreditation organization or the OHCQ; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#E(3)">(3)</span> Other inspections by the OHCQ to determine if the tissue bank is in compliance with licensure requirements.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#F">F.</span> Notice of Deficiencies. If a survey identifies noncompliance with a requirement, the Department shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#F(1)">(1)</span> Issue a written Statement of Deficiencies that cites each deficiency;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#F(2)">(2)</span> Require the tissue bank to submit an acceptable plan of correction within 10 calendar days of receipt of the Statement of Deficiencies;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#F(3)">(3)</span> Notify the tissue bank of any sanctions imposed or that failure to correct the violation may result in sanctions; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#F(4)">(4)</span> Offer the tissue bank the opportunity for informal dispute resolution (IDR).</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#G">G.</span> Plan of Correction.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#G(1)">(1)</span> The tissue bank shall submit a written plan of correction to the OHCQ in response to a Statement of Deficiencies documenting the steps the permit holder will take to come into compliance, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#G(1)(a)">(a)</span> How the tissue bank will correct each deficiency;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#G(1)(b)">(b)</span> The date by which each deficient practice will be corrected;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#G(1)(c)">(c)</span> How the tissue bank will prevent the deficient practice from recurring; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#G(1)(d)">(d)</span> Who will be responsible for ensuring the deficiency will not reoccur.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#G(2)">(2)</span> Failure of the tissue bank to return an acceptable plan of correction within 10 calendar days after receipt of a Statement of Deficiencies may result in a sanction.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#G(3)">(3)</span> A tissue bank’s request for an IDR does not change the tissue bank's requirement to submit a plan of correction for all deficiencies within 10 calendar days after receipt of the Statement of Deficiencies.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#G(4)">(4)</span> If an immediate jeopardy is identified during a survey, the tissue bank’s plan of correction shall completely correct all noncompliance associated with the immediate jeopardy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#H">H.</span> Immediate Jeopardy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#H(1)">(1)</span> Declaration of Immediate Jeopardy.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#H(1)(a)">(a)</span> When the Department identifies a situation in which immediate corrective action is necessary because the tissue bank's noncompliance with one or more licensure requirements has already caused, is causing, or is likely to cause, at any time, serious harm or death, to individuals served by the tissue bank or to the health or safety of the general public, an immediate jeopardy will be declared.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#H(1)(b)">(b)</span> The Department shall provide the tissue bank a written notice that includes a description of the situation that constitutes an immediate jeopardy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#H(2)">(2)</span> Removal Plan.  The tissue bank shall submit a written removal plan to the Department that includes:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#H(2)(a)">(a)</span> The immediate corrective action a tissue bank will take to prevent serious harm from occurring or recurring;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#H(2)(b)">(b)</span> All actions to remove past, present, and future jeopardy; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#H(2)(c)">(c)</span> The date by which the entity asserts the likelihood for serious harm to any recipient or the general public will no longer exist.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#H(3)">(3)</span> The Department’s Review of the Removal Plan.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#H(3)(a)">(a)</span> The OHCQ staff shall review the tissue bank's removal plan to determine if the removal plan, if implemented appropriately, will remove the likelihood that serious harm will occur, or recur.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#H(3)(b)">(b)</span> The OHCQ shall verify that the tissue bank has implemented the removal plan.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#H(4)">(4)</span> The Department’s Approval of the Removal Plan. The Department shall approve the removal plan after verifying that all actions the tissue bank took were effective in removing the likelihood that serious harm or death would occur or recur.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#I">I.</span> Informal Dispute Resolution (IDR).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#I(1)">(1)</span> A tissue bank may request an IDR to dispute one or more deficiencies in a Statement of Deficiencies.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#I(2)">(2)</span> The tissue bank shall submit the request for an IDR to the OHCQ within 10 calendar days of receiving the Statement of Deficiencies.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#I(3)">(3)</span> The written request for an IDR shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#I(3)(a)">(a)</span> Fully describe the disagreement with the Statement of Deficiencies; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#I(3)(b)">(b)</span> Include all accompanying evidence for the OHCQ’s consideration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#I(4)">(4)</span> At the discretion of the OHCQ, the IDR may be held in person, by telephone, by video conference, or in writing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#I(5)">(5)</span> IDRs are informal in nature and may not be attended by legal counsel representing the tissue bank or the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#I(6)">(6)</span> The IDR process may not delay the effective date of any enforcement action.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#I(7)">(7)</span> In the event a tissue bank requests an IDR for a Statement of Deficiencies written by a designee of the Department, the Department shall request the designee to participate in the IDR process.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#I(8)">(8)</span> There is no appeal of the Department’s decision in an IDR.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.08#J">J.</span> Process of Filing a Complaint. The tissue bank shall have a written process that describes how donors and recipients of tissue bank services are notified of how to file a complaint with the OHCQ and, if applicable, an accreditation organization.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.50.01.09" data-order="|10|50|01|.09|" data-ref-path="10|50|01|.09" class="h__section">.09 Tissue Bank Standards — General.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.09#A">A.</span> Applicable Laws. A tissue bank shall comply with all requirements and standards in this chapter as well as with other applicable federal, State, and local laws, regulations, and rules.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.09#B">B.</span> Governing Body. Unless provided by the institution of which it is a part, a tissue bank shall have a governing body consisting of individuals from various professions, that determines the scope of activities to be pursued by the tissue bank and is responsible for issues of:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.09#B(1)">(1)</span> Liability;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.09#B(2)">(2)</span> Ethical considerations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.09#B(3)">(3)</span> Fiduciary responsibility; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.09#B(4)">(4)</span> Compliance with the standards and requirements of this chapter and those of the tissue bank's standard operating procedure manual.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.09#C">C.</span> Facilities.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.09#C(1)">(1)</span> General. The physical facilities of a tissue bank shall meet all applicable federal, State, and local laws, including but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.09#C(1)(a)">(a)</span> Engineering;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.09#C(1)(b)">(b)</span> Fire;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.09#C(1)(c)">(c)</span> Safety;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.09#C(1)(d)">(d)</span> Health; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.09#C(1)(e)">(e)</span> Sanitation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.09#C(2)">(2)</span> Physical Plant. The physical plant of a tissue bank shall be designed or arranged to meet operational needs with plumbing, drainage, lighting, ventilation, space, and handwashing facilities for personnel and donors if applicable.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.09#C(3)">(3)</span> Designated Space. Personnel of a tissue bank shall perform the following critical tissue bank procedures in designated areas:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.09#C(3)(a)">(a)</span> Processing;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.09#C(3)(b)">(b)</span> Quarantine storage of in-process materials;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.09#C(3)(c)">(c)</span> Other quarantining;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.09#C(3)(d)">(d)</span> Labeling;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.09#C(3)(e)">(e)</span> Storage of distributable inventory;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.09#C(3)(f)">(f)</span> Quality assurance and control functions;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.09#C(3)(g)">(g)</span> Receipt and storage of containers, supplies, and reagents;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.09#C(3)(h)">(h)</span> Storage of medical waste;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.09#C(3)(i)">(i)</span> Irradiation and other sterilization procedures; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.09#C(3)(j)">(j)</span> Final product inspection and distribution activities.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.50.01.10" data-order="|10|50|01|.10|" data-ref-path="10|50|01|.10" class="h__section">.10 Tissue Bank Standards — Personnel.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#A">A.</span> General Requirements. A tissue bank shall employ a technical director, medical director, and sufficient staff to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#A(1)">(1)</span> Provide accurate and reliable services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#A(2)">(2)</span> Meet all operational needs; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#A(3)">(3)</span> Meet all statutory and regulatory requirements and standards.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#B">B.</span> Medical Director.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#B(1)">(1)</span> Qualifications. The medical director:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#B(1)(a)">(a)</span> Shall be a physician licensed to practice medicine by the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#B(1)(a)(i)">(i)</span> Maryland Board of Physicians; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#B(1)(a)(ii)">(ii)</span> Appropriate agency in the state where the tissue bank is located; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#B(1)(b)">(b)</span> Shall be qualified by training and experience in evaluating and determining donor suitability, particularly with regard to infectious diseases.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#B(2)">(2)</span> Serving as Technical Director. The medical director may serve also as the technical director if the medical director remains at the tissue bank site during the tissue bank's regular hours of operation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#B(3)">(3)</span> Responsibilities. The medical director shall be responsible for all medical aspects of the tissue bank's operations and shall retain overall responsibility when a task is delegated to a designated qualified employee. The medical director or the designated qualified employee shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#B(3)(a)">(a)</span> Establish donor suitability criteria;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#B(3)(b)">(b)</span> Evaluate and determine each donor's acceptability;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#B(3)(c)">(c)</span> Review and approve the standard operating procedures, quality assurance policies, and quality control records for medical efficacy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#B(3)(d)">(d)</span> Approve exceptional or extraordinary releases of tissue as specified in the tissue bank's standard operating procedure manual;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#B(3)(e)">(e)</span> Establish policies and procedures regarding adverse outcomes that include requiring that all potential adverse outcomes are:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#B(3)(e)(i)">(i)</span> Investigated;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#B(3)(e)(ii)">(ii)</span> Documented;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#B(3)(e)(iii)">(iii)</span> Reviewed; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#B(3)(e)(iv)">(iv)</span> Reported as required by applicable federal, State, or local law;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#B(3)(f)">(f)</span> Notify the living donor or, for a cadaveric donor, the cadaveric donor's physician for any legally allowed counseling of next of kin, of confirmed positive infectious disease test results;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#B(3)(g)">(g)</span> Notify the OHCQ in writing or electronically of each fatal adverse outcome related to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#B(3)(g)(i)">(i)</span> Transplantation;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#B(3)(g)(ii)">(ii)</span> Transfusion;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#B(3)(g)(iii)">(iii)</span> Transfer; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#B(3)(g)(iv)">(iv)</span> Implementation of tissue; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#B(3)(h)">(h)</span> Establish look back and recall procedures when tissue is determined to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#B(3)(h)(i)">(i)</span> Be defective; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#B(3)(h)(ii)">(ii)</span> May potentially cause an adverse outcome.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#C">C.</span> Technical Director.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#C(1)">(1)</span> Qualifications. The technical director shall be qualified by training and experience for the scope of activities being pursued and have:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#C(1)(a)">(a)</span> A bachelor's or higher degree in medical technology or a biological science from an accredited college or university and be qualified by training and experience for the scope of activities conducted by the tissue bank;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#C(1)(b)">(b)</span> A bachelor’s degree in a discipline other than medical technology or a biological science from an accredited college or university and have 5 years of experience overseeing all technical aspects of tissue bank operations under the supervision of a medical director; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#C(1)(c)">(c)</span> Licensure as a registered nurse in the state that the tissue bank is operating.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#C(2)">(2)</span> Responsibilities. The technical director shall oversee and be responsible for all technical aspects of the tissue bank's operations and shall retain overall responsibility when a task is delegated to a designated qualified employee. The technical director or designated qualified employee shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#C(2)(a)">(a)</span> Provide on-site supervision of tissue bank operations and personnel during the tissue bank's regular hours of operation; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#C(2)(b)">(b)</span> Participate in and actively supervise the tissue bank's:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#C(2)(b)(i)">(i)</span> Planning;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#C(2)(b)(ii)">(ii)</span> Organization;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#C(2)(b)(iii)">(iii)</span> Staffing;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#C(2)(b)(iv)">(iv)</span> Training and continuing education;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#C(2)(b)(v)">(v)</span> Staff competency;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#C(2)(b)(vi)">(vi)</span> Quality control and quality assurance;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#C(2)(b)(vii)">(vii)</span> Standard operating procedures (SOPs);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#C(2)(b)(viii)">(viii)</span> Facilities;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#C(2)(b)(ix)">(ix)</span> Donor selection;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#C(2)(b)(x)">(x)</span> Equipment;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#C(2)(b)(xi)">(xi)</span> Products;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#C(2)(b)(xii)">(xii)</span> Records;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#C(2)(b)(xiii)">(xiii)</span> Services; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#C(2)(b)(xiv)">(xiv)</span> Compliance with the requirements and standards of this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#D">D.</span> Technical Staff.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#D(1)">(1)</span> Qualifications.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#D(1)(a)">(a)</span> Technical staff shall possess the education, experience, and training necessary and sufficient to assure that assigned tasks are performed in accordance with the tissue bank's established procedures and the standards set forth in this chapter.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#D(1)(b)">(b)</span> The technical director or the designated qualified employee, and medical director or the designated qualified employee shall train individual staff to accurately and reliably:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#D(1)(b)(i)">(i)</span> Perform tissue bank services such as collection, retrieval, processing, packaging, and cryopreservation; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#D(1)(b)(ii)">(ii)</span> Document that training in the individual's employee training file.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#D(2)">(2)</span> Responsibilities.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#D(2)(a)">(a)</span> Technical staff shall implement, maintain, and follow the policies and procedures established by the medical director and technical directors.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#D(2)(b)">(b)</span> A technical director or the designated qualified employee shall list and describe the duties and responsibilities of technical staff in written job descriptions.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#D(2)(c)">(c)</span> Technical staff shall initially, and at least annually thereafter, demonstrate documented competency in the tasks to which the staff person is assigned.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.10#D(2)(d)">(d)</span> Technical staff shall participate in documented training and continuing education to maintain technical competency in the duties described in their written job descriptions.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.50.01.11" data-order="|10|50|01|.11|" data-ref-path="10|50|01|.11" class="h__section">.11 Tissue Bank Standards — Testing to Minimize Disease Transmission.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#A">A.</span> Required Testing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#A(1)">(1)</span> General — All Donors. A permit holder shall ensure that a prospective donor of tissue, including both leukocyte-rich and leukocyte-poor cell and tissue, intended to be used as an allograft is tested for biochemical, immunological, or serological evidence of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#A(1)(a)">(a)</span> Hepatitis B virus (HBV);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#A(1)(b)">(b)</span> Hepatitis C virus (HCV);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#A(1)(c)">(c)</span> Human immunodeficiency virus type 1 (HIV-1);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#A(1)(d)">(d)</span> Human immunodeficiency virus type 2 (HIV-2); and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#A(1)(e)">(e)</span> Treponema pallidum (syphilis).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#A(2)">(2)</span> Specific — Donors of Specific Tissue or Cell Types.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#A(2)(a)">(a)</span> In addition to those tests set forth in <a class="internal-link " href="/us/md/exec/comar/10.50.01.11#A(1)" title="">§A(1) of this regulation</a>, a permit holder shall ensure that a prospective donor of specific types of tissue are tested in accordance with the requirements set forth in §A(2)(b)—(c) of this regulation.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#A(2)(b)">(b)</span> Donors of Leukocyte-Rich Tissue. A permit holder shall ensure that a prospective donor of a leukocyte-rich tissue, as defined in <a class="internal-link " href="/us/md/exec/comar/10.50.01.03#B" title="">Regulation .03B of this chapter</a>, intended to be used as an allograft, is tested for biochemical, immunological, or serological evidence of:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#A(2)(b)(i)">(i)</span> Human T-lymphotropic virus type I (HTLV-I);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#A(2)(b)(ii)">(ii)</span> Human T-lymphotropic virus type II (HTLV-II); and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#A(2)(b)(iii)">(iii)</span> Cytomegalovirus (CMV).</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#A(2)(c)">(c)</span> Donors of Reproductive Tissue including Oocytes and Semen. In addition to those applicable tests set forth in §A(1) and (2)(a) of this regulation, a permit holder shall ensure that a prospective donor of reproductive tissue, as defined in <a class="internal-link " href="/us/md/exec/comar/10.50.01.03#B" title="">Regulation .03B of this chapter</a>, intended to be used as an allograft, is tested for biochemical, immunological, or serological evidence of:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#A(2)(c)(i)">(i)</span> Chlamydia trachomatis; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#A(2)(c)(ii)">(ii)</span> Neisseria gonorrhoeae.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#B">B.</span> Required Laboratory Licensure.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#B(1)">(1)</span> In-House Testing Services. A tissue bank that conducts its own testing on human specimens shall possess a Maryland license to operate a medical laboratory and comply with all applicable standards as set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.01" title="Chapter 01 General">COMAR 10.10.01</a>—10.10.08.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#B(2)">(2)</span> Contractual Testing Services. A tissue bank that contracts for laboratory testing services shall obtain and maintain:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#B(2)(a)">(a)</span> The name and address of a contracted facility and documentation of the inclusive dates of the contract period; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#B(2)(b)">(b)</span> Proof of the contracted facility's current:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#B(2)(b)(i)">(i)</span> Federal certification;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#B(2)(b)(ii)">(ii)</span> Required State laboratory licensure; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#B(2)(b)(iii)">(iii)</span> Accreditation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#B(3)">(3)</span> Other Testing Services. A tissue bank that obtains test results from a noncontracted laboratory, for example, another tissue bank or an organ retrieval organization, shall obtain and maintain the name, address, and licensing and accreditation information for each laboratory from which test results are obtained for the purpose of donor assessment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#C">C.</span> Confidentiality and Release of Test Results. A technical director of a tissue bank may release results of laboratory tests performed by the tissue bank holding a medical laboratory license or performed for the tissue bank by another licensed laboratory only:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#C(1)">(1)</span> To:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#C(1)(a)">(a)</span> The medical director of the tissue bank;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#C(1)(b)">(b)</span> An authorized person who requested the test; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#C(1)(c)">(c)</span> Another laboratory that requested the test as set forth under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.10.06.04" title=".04 Reporting and Releasing Test Results.">COMAR 10.10.06.04</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#C(2)">(2)</span> As allowed under the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#C(2)(a)">(a)</span> Maryland Confidentiality of Medical Records Act, Health-General Article, Title 4, Subtitle 3, Annotated Code of Maryland; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#C(2)(b)">(b)</span> Federal:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#C(2)(b)(i)">(i)</span> Health Insurance Portability and Accountability Act (HIPAA), 42 U.S.C. §§1320d et seq.;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#C(2)(b)(ii)">(ii)</span> Health Information Technology for Economic and Clinical Health (HITECH) Act, 42 U.S.C. §§17921 et seq.; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.50.01.11#C(2)(b)(iii)">(iii)</span> Implementing rules and regulations for HIPAA and the HITECH Act set forth at 45 CFR Parts 160, 162, and 164.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.50.01.12" data-order="|10|50|01|.12|" data-ref-path="10|50|01|.12" class="h__section">.12 Tissue Bank Standards — Technical.</h3>
                <p>In addition to the requirements and standards in this chapter, a tissue bank shall meet and comply, where applicable, with the following technical requirements and standards:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.12#A">A.</span> Records management, in the manner prescribed in Section C of Standards for Tissue Banking;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.12#B">B.</span> Tissue acquisition, in the manner prescribed in Section D of Standards for Tissue Banking;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.12#C">C.</span> Processing, preservation, quarantine, and storage, in the manner prescribed in Section E of Standards for Tissue Banking;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.12#D">D.</span> Release and transfer of tissue, in the manner prescribed in Section F of Standards for Tissue Banking;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.12#E">E.</span> Labeling, in the manner prescribed in Section G of Standards for Tissue Banking;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.12#F">F.</span> Distribution and dispensing, in the manner prescribed in Section H of Standards for Tissue Banking;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.12#G">G.</span> General operations, in the manner prescribed in Section J of Standards for Tissue Banking;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.12#H">H.</span> Quality assurance, in the manner prescribed in Section K of Standards for Tissue Banking;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.12#I">I.</span> Tissue dispensing services, in the manner prescribed in Section L of Standards for Tissue Banking;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.12#J">J.</span> Tissue distribution intermediaries, in the manner prescribed in subsections M1-8 of Standards for Tissue Banking; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.50.01.12#K">K.</span> Standards for Blood Banks and Transfusion Services.</p>
                <hr class="section-separator" aria-hidden="true"/>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/10.49" aria-label="Subtitle 49 STATE ANATOMY BOARD">
                <div class="h__ui">Previous</div>
                <span>Subtitle 49 STATE ANATOMY BOARD</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/10.51" aria-label="Subtitle 51 FORENSIC LABORATORIES">
                <div class="h__ui">Next</div>
                <span>Subtitle 51 FORENSIC LABORATORIES</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">
<p>This version of the laws and codes on this website is licensed under the <a href="https://creativecommons.org/licenses/by-nc-sa/4.0/">CC BY-NC-SA 4.0</a> license with copyright held by the State of Maryland.</p><p>This version of the laws and codes on this website will be dedicated to the public domain under the <a href="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0</a> license 180 days after publication.</p>
<p>
      Please do not scrape. Instead, bulk download the CC BY-NC-SA-4.0 <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a> or CC0 <a href="https://github.com/maryland-dsd/law-html-cc0">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml-cc0">XML</a>.
    </p><p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p></div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
